We are live on ! Find out more
PCS

Personal CFO Solutions Portfolio holdings

AUM $712M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+25.3%
3 Year Est. Return
+74.76%
5 Year Est. Return
+83.43%
10 Year Est. Return
AUM
$578M
AUM Growth
+$71.6M
Cap. Flow
+$20.8M
Cap. Flow %
3.61%
Top 10 Hldgs %
26.83%
Holding
553
New
98
Increased
237
Reduced
163
Closed
42

Sector Composition

Rank Sector Weight
1 Financials 14.73%
2 Technology 12.95%
3 Healthcare 8.2%
4 Consumer Discretionary 6.25%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKK icon
276
ARK Innovation ETF
ARKK
$5.89B
$425K 0.07%
8,109
+397
+5% +$17.2K
OZK icon
277
Bank OZK
OZK
$5.49B
$422K 0.07%
8,465
+329
+4% +$13.6K
TNL icon
278
Travel + Leisure Co
TNL
$4.54B
$422K 0.07%
10,787
+51
+0.5% +$1.85K
CAT icon
279
Caterpillar
CAT
$409B
$420K 0.07%
1,419
+164
+13% +$42.5K
KHC icon
280
Kraft Heinz
KHC
$30.4B
$420K 0.07%
11,344
+168
+2% +$5.71K
QUAL icon
281
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$418K 0.07%
+2,842
New +$393K
OUSA icon
282
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$737M
$417K 0.07%
9,050
-2,420
-21% -$105K
TSN icon
283
Tyson Foods
TSN
$20.2B
$409K 0.07%
7,616
-2,545
-25% -$124K
CDNS icon
284
Cadence Design Systems
CDNS
$90B
$408K 0.07%
1,499
+126
+9% +$32.5K
KOCT icon
285
Innovator US Small Cap Power Buffer ETF October
KOCT
$143M
$404K 0.07%
+14,684
New +$380K
VRTX icon
286
Vertex Pharmaceuticals
VRTX
$121B
$402K 0.07%
989
-74
-7% -$27.3K
JCPB icon
287
JPMorgan Core Plus Bond ETF
JCPB
$13.8B
$402K 0.07%
+8,544
New +$386K
ACAD icon
288
Acadia Pharmaceuticals
ACAD
$4.25B
$402K 0.07%
12,828
+20
+0.2% +$478
EEMV icon
289
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$401K 0.07%
7,207
+547
+8% +$29.3K
UNP icon
290
Union Pacific
UNP
$183B
$400K 0.07%
1,627
+220
+16% +$48.4K
NSP icon
291
Insperity
NSP
$1.85B
$399K 0.07%
3,406
+169
+5% +$18.3K
MTRN icon
292
Materion
MTRN
$5.01B
$399K 0.07%
3,062
-334
-10% -$36.6K
BCRX icon
293
BioCryst Pharmaceuticals
BCRX
$2.37B
$397K 0.07%
66,303
-453
-0.7% -$2.63K
PRGO icon
294
Perrigo
PRGO
$1.4B
$397K 0.07%
12,335
-594
-5% -$17.8K
ITOT icon
295
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
$396K 0.07%
3,764
+67
+2% +$6.57K
MUFG icon
296
Mitsubishi UFJ Financial
MUFG
$258B
$396K 0.07%
45,982
-404
-0.9% -$3.41K
FMX icon
297
Fomento Económico Mexicano
FMX
$43.3B
$395K 0.07%
3,027
-209
-6% -$24.9K
FOXA icon
298
Fox Class A
FOXA
$23.2B
$394K 0.07%
13,283
+216
+2% +$6.53K
AJG icon
299
Arthur J. Gallagher & Co
AJG
$63.7B
$389K 0.07%
1,731
+120
+7% +$28.4K
CNS icon
300
Cohen & Steers
CNS
$4.18B
$388K 0.07%
5,129
-48
-0.9% -$2.89K

Similar funds

Personal CFO Solutions's Q4 2023 Portfolio in Review

As of Q4 2023, Personal CFO Solutions held 553 positions worth $578M, up 14% from $506M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Personal CFO Solutions deployed $20.8M of net new capital in Q4 2023, opening 98 new positions and adding to 237 existing holdings. Its largest new stake was CBRE Group: 17,458 shares worth $1.63M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Fidelity MSCI Health Care Index ETF, an estimated $3.69M trimmed.

  • Personal CFO Solutions's largest Q4 2023 buy was CBRE Group: 17,458 shares worth $1.63M.
  • Personal CFO Solutions added most to Fidelity MSCI Information Technology Index ETF in Q4 2023, an estimated $4.33M increase.
  • Personal CFO Solutions's biggest Q4 2023 reduction was Fidelity MSCI Health Care Index ETF, cutting an estimated $3.69M.
  • Personal CFO Solutions fully exited Fidelity MSCI Consumer Staples Index ETF in Q4 2023, selling an estimated $4.65M.
  • Personal CFO Solutions's ten largest holdings make up 27% of its $578M portfolio in Q4 2023.
  • Personal CFO Solutions opened 98 new positions and closed 42 in Q4 2023.
  • Personal CFO Solutions's portfolio value rose 14% quarter-over-quarter to $578M.

Based on Personal CFO Solutions's 13F filing for Q4 2023, filed 13 Feb 2024.